Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Holders of 5% or more of OMIC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Singular Genomics Systems, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Flynn James E | 13D/A | 100.00%1.00K shares | +93.38 ppfrom 6.62% | Dec 26, 20242 filings | Feb 25, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Singular Genomics Systems, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20255:05 PM ET | ARCH Venture Fund IX, L.P.and 5 others | 13G/A | 0.00%0 shares | –Below 5% | Feb 21, 2025 | SEC |
| Feb 25, 20259:18 PM ET | Flynn James Eand 3 others | 13D/A | 100.00%1.00K shares | +93.38 ppfrom 6.62% | Feb 21, 2025 | SEC |
| Jan 16, 20252:52 PM ET | Domain Partners IX, L.P.and 1 other | 13G/A | 4.95%125.4K shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 26, 20248:55 PM ET | Flynn James Eand 3 others | 13D/A | 6.62%249.5K shares | – | Dec 22, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Singular Genomics Systems, Inc. shares.
No Form 144 notices for Singular Genomics Systems, Inc. are on file.